Pharmaceutical

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales…

3 months ago

Introducing Perceptive: A New Name for the Global Leader in Discovery, eClinical, and Imaging Services and Solutions

Calyx and Invicro rebrand, usher in a new era of leadership and support to the biopharmaceutical community NOTTINGHAM, England, Sept. 30,…

3 months ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS) ("Biophytis" or the…

3 months ago

Spectra Medical Devices Acquires XL Precision Technologies

WILMINGTON, Mass. & STOCKTON-ON-TEES, England--(BUSINESS WIRE)--Spectra Medical Devices, LLC (“Spectra”), a portfolio company of QHP Capital, is pleased to announce…

3 months ago

MSD in Strategic collaboration with Briya for Innovative RWE data analysis projects

TEL AVIV, Israel, Sept. 30, 2024 /PRNewswire/ -- MSD, a leading multinational pharmaceutical company successfully completes a first-of-its-kind strategic collaboration…

3 months ago

Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky

$80M investment plan will add commercial scale sterile injectables capabilities Expansion will significantly increase production capacity and operational efficiency  Lexington facility…

3 months ago

Waud Capital Partners Acquires Science Exchange to Fuel Innovation in Life Sciences Supplier Orchestration Technology

Science Exchange Poised for Transformative Growth with Backing from Leading Private Equity Firm CHICAGO, Sept. 30, 2024 /PRNewswire/ -- Waud…

3 months ago

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)

Academic group to receive a total of $22 million for the trialLA JOLLA, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) --…

3 months ago

Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules

SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its…

3 months ago